Failure of acyclovir to prevent cytomegalovirus infection in renal allograft recipients*
β Scribed by TONY Wong; SYLVIE Lavaud; OLIVIER Toupance; JOCELYNE Carquin; ALAIN Wynckel; JEAN-PIERRE Melin; CATHERINE Hanrotel; JACQUES Chanard
- Book ID
- 115134197
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 554 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The relative merits of antibody response and virus shedding as markers of cytomegalovirus (CMV) infection among cyclosporinβtreated renal allograft recipients were analysed. CMVβspecific antibody was assayed by lgGβspecific radioimmunosorbent test (RIST) and by complement fixation test
High dose oral acyclovir has been reported to be effective in preventing both cytomegalovirus (CMV) infection and disease in renal transplant recipients. We conducted a case-controlled study in which 42 cadaveric kidney transplant recipients were prophylactically treated with high dose oral acyclovi
## Abstract Serum complement profiles of 19 renal transplant recipients were studied serially before and after renal transplantation to determine if there is any relationship between cytomegalovirus (CMV) infection and alteration in the serum complement (C) levels. Most patients had low serum C3 an